Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.88%
#2 Pons Pons +38.42%
#3 PondCoin PondCoin +38.08%
#4 Purr Purr +30.23%
#5 TENDIES TENDIES +30.09%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.85%
#7 Magma Finance Magma Finance +27.70%
#8 Starpower Starpower +26.83%
#9 StonkBroker StonkBroker +26.40%
#10 SkyAI SkyAI +24.68%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
HTG Molecular Diagnostics, Inc. HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc.

HTGM
Rank in Stocks #28757
Based in Tucson, Arizona, HTG Molecular Diagnostics, Inc. is a life sciences... Based in Tucson, Arizona, HTG Molecular Diagnostics, Inc. is a life sciences company dedicated to advancing precision medicine. They provide a comprehensive suite of products, including specialized instruments, assay kit consumables, and software solutions, all designed to automate sample processing and accurately profile various molecular targets. Their extensive portfolio features numerous molecular profiling panels, such as the HTG Transcriptome Panel, HTG EdgeSeq precision immuno-oncology panel, HTG EdgeSeq miRNA whole-transcriptome assay, HTG EdgeSeq DLBCL cell of origin assay (available in both EU and non-EU versions), HTG EdgeSeq Oncology Biomarker Panel, HTG EdgeSeq ALKPlus assay EU, HTG EdgeSeq Pan B-Cell Lymphoma Panel, HTG immune response panel, and HTG mouse mRNA tumor response panel. The company directly distributes its instruments and consumables across the United States and Europe, while utilizing distributors for other international markets and specific European regions. Their diverse clientele includes biopharmaceutical companies, academic research centers, and molecular testing laboratories. Additionally, HTG Molecular Diagnostics, Inc. maintains a governing agreement with QIAGEN Manchester Limited. The company was founded in 1997 as HTG, Inc., and officially changed its name to HTG Molecular Diagnostics, Inc. in March 2011.
Share Price
$0.48
Last synced: 2023-06-14
Market Cap
$24.79M
Change (1 day)
-20.00%
Change (1 year)
0.00%
Country
US
Trade HTG Molecular Diagnostics, Inc. (HTGM)

Category

Healthcare
Operating Margin for HTG Molecular Diagnostics, Inc. (HTGM)
Operating Margin as of 2026 TTM: 0.00%
According to HTG Molecular Diagnostics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for HTG Molecular Diagnostics, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
17.69% -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
20.42% -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
0.00% -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
-10.70% -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
32.03% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.